IVDA:NASDAQIveda Solutions, Inc. Analysis
Data as of 2026-04-11 - not real-time
$0.26
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Iveda Solutions trades at $0.2555, hovering just above its computed support of $0.23 and well below the 20‑day SMA of $0.2775, signaling a fragile price footing. Technical gauges are mixed: the RSI sits at 35.4 (Volatility is extreme at 57.5% over 30 days and the stock’s beta of 2.36 points to amplified market swings. Fundamentally, the company is in distress – revenue has collapsed by 64%, margins are deeply negative (operating margin –2.63%, profit margin –60.6%), and cash flow is negative, with a max drawdown of –91.5% and a market cap of only $2.85 M. No dividend is paid, and the balance sheet shows a high debt‑to‑equity ratio of 14.8, underscoring liquidity concerns.
Given the confluence of a low‑priced, highly volatile stock with deteriorating fundamentals and limited liquidity, the outlook remains precarious. While the MACD hints at a short‑term technical bounce, the broader financial health and market sentiment (Fear & Greed Index at “Extreme Greed”) suggest that any upside is speculative and heavily risk‑weighted.
Given the confluence of a low‑priced, highly volatile stock with deteriorating fundamentals and limited liquidity, the outlook remains precarious. While the MACD hints at a short‑term technical bounce, the broader financial health and market sentiment (Fear & Greed Index at “Extreme Greed”) suggest that any upside is speculative and heavily risk‑weighted.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price near support with limited upside
- Mixed technical signals but overall bearish trend
- Severe negative earnings and cash flow
Medium Term
1–3 yearsCautious
Model confidence: 8/10
Key Factors
- Continued revenue decline and widening losses
- High volatility and beta amplifying market risk
- Liquidity constraints reflected by low market cap and decreasing volume
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Fundamental restructuring required to reverse negative margins
- Risk of further capital erosion given high debt‑to‑equity
- Unclear path to sustainable growth in a competitive security services market
Key Metrics & Analysis
Financial Health
Revenue Growth-64.10%
Profit Margin-60.57%
P/E Ratio0.1
ROE-87.80%
ROA-34.75%
Debt/Equity14.84
P/B Ratio0.3
Op. Cash Flow$-2027501
Free Cash Flow$-919520
Industry P/E30.9
Technical Analysis
TrendBearish
RSI35.4
Support$0.23
Resistance$0.38
MA 20$0.28
MA 50$0.35
MA 200$1.14
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.36
Volatility57.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.